Appropriate dosing of burosumab in tumor-induced osteomalacia

  • Osteoporos Int. 2022 Dec 1. doi: 10.1007/s00198-022-06617-2.
Luciano Colangelo  1 ,  Chiara Sonato  1 ,  Mara Riminucci  2 ,  Alessandro Corsi  3 ,  Salvatore Minisola  1
Affiliations
  • 1. Department of Clinical, Internal, Anesthesiologic and Cardiovascular Sciences, Sapienza University of Rome, Rome, Italy.
  • 2. Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy.
  • 3. Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy. [email protected].
PMID: 36454246 DOI: 10.1007/s00198-022-06617-2
Products